Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhibitor and minimal residual disease (Q37632798)

From Wikidata
Jump to navigation Jump to search
scientific article published on 30 August 2013
edit
Language Label Description Also known as
English
Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhibitor and minimal residual disease
scientific article published on 30 August 2013

    Statements

    Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhibitor and minimal residual disease (English)
    V Bachanova
    D I Marks
    M-J Zhang
    M de Lima
    M D Aljurf
    M Arellano
    A S Artz
    U Bacher
    J-Y Cahn
    Y-B Chen
    E A Copelan
    W R Drobyski
    R P Gale
    J P Greer
    V Gupta
    G A Hale
    P Kebriaei
    H M Lazarus
    I D Lewis
    V A Lewis
    A M Miller
    M Norkin
    B Oran
    J Pidala
    J M Rowe
    B N Savani
    W Saber
    E K Waller
    D J Weisdorf
    30 August 2013
    658-665

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit